445 related articles for article (PubMed ID: 22971158)
1. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.
Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V
Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.
Hermanns-Clausen M; Kithinji J; Spehl M; Angerer V; Franz F; Eyer F; Auwärter V
Drug Test Anal; 2016 Oct; 8(10):1030-1038. PubMed ID: 26768345
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.
Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jul; 47(7):825-35. PubMed ID: 22791249
[TBL] [Abstract][Full Text] [Related]
4. Toxicological findings of synthetic cannabinoids in recreational users.
Kronstrand R; Roman M; Andersson M; Eklund A
J Anal Toxicol; 2013 Oct; 37(8):534-41. PubMed ID: 23970540
[TBL] [Abstract][Full Text] [Related]
5. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
Every-Palmer S
Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
[TBL] [Abstract][Full Text] [Related]
6. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
7. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens.
Arntson A; Ofsa B; Lancaster D; Simon JR; McMullin M; Logan B
J Anal Toxicol; 2013 Jun; 37(5):284-90. PubMed ID: 23625703
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples.
Dresen S; Kneisel S; Weinmann W; Zimmermann R; Auwärter V
J Mass Spectrom; 2011 Feb; 46(2):163-71. PubMed ID: 21259394
[TBL] [Abstract][Full Text] [Related]
9. Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers.
Salomone A; Luciano C; Di Corcia D; Gerace E; Vincenti M
Drug Test Anal; 2014; 6(1-2):126-34. PubMed ID: 24115381
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.
Young AC; Schwarz E; Medina G; Obafemi A; Feng SY; Kane C; Kleinschmidt K
Am J Emerg Med; 2012 Sep; 30(7):1320.e5-7. PubMed ID: 21802885
[TBL] [Abstract][Full Text] [Related]
11. Blood synthetic cannabinoid concentrations in cases of suspected impaired driving.
Yeakel JK; Logan BK
J Anal Toxicol; 2013 Oct; 37(8):547-51. PubMed ID: 23965292
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of an on-site drug-testing device for the detection of synthetic cannabinoids in illegal herbal products].
Uchiyama N; Kikura-Hanajiri R; Hakamatsuka T
Yakugaku Zasshi; 2015; 135(3):535-41. PubMed ID: 25759062
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period.
Tuv SS; Krabseth H; Karinen R; Olsen KM; Øiestad EL; Vindenes V
Accid Anal Prev; 2014 Jan; 62():26-31. PubMed ID: 24129318
[TBL] [Abstract][Full Text] [Related]
15. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.
Hutter M; Broecker S; Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jan; 47(1):54-65. PubMed ID: 22282090
[TBL] [Abstract][Full Text] [Related]
16. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
17. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre.
Cairns R; Brown JA; Gunja N; Buckley NA
Int J Drug Policy; 2017 May; 43():74-82. PubMed ID: 28343112
[TBL] [Abstract][Full Text] [Related]
18. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
Ammann J; McLaren JM; Gerostamoulos D; Beyer J
J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
[TBL] [Abstract][Full Text] [Related]
19. Identification and structural elucidation of four cannabimimetic compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in seized products.
Denooz R; Vanheugen JC; Frederich M; de Tullio P; Charlier C
J Anal Toxicol; 2013 Mar; 37(2):56-63. PubMed ID: 23339188
[TBL] [Abstract][Full Text] [Related]
20. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
